Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exparel Versus Bupivacaine in Post-operative Pain Control
Sponsor: Case Western Reserve University
Summary
This is a prospective, randomized study to evaluate anaesthetic parameters, postoperative analgesia and oral analgesic consumption comparing exparel (liposomal bupivacaine) vs. standard bupivacaine
Official title: Exparel Versus Bupivacaine in Post-operative Pain Control Following Bilateral Third Molar Extractions: A Single-blind Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-08-21
Completion Date
2025-07-01
Last Updated
2026-07-28
Healthy Volunteers
Yes
Conditions
Interventions
Bupivacaine liposome injectable suspension
At the end of the third molar extraction surgical procedure performed under general anesthesia and at least fifteen minutes following the most recent administration of 2% lidocaine with 1:100,000 epinephrine nerve block (routine for this procedure), all patients will receive bilateral infiltrations with 3mL of 1.3% liposomal bupivacaine (Exparel) OR with 3mL of 0.5% bupivacaine with 1:200,000 epinephrine while they are still under general anesthesia.
Locations (1)
Case Western Reserve University
Cleveland, Ohio, United States